Daniel Pharand

Guest Contributor
October 10, 2001

Daniel Pharand has been appointed executive VP business development of PanGeo Pharma Inc, a Montreal-based contract manufacturer providing formulation development and sale distribution services to multinational drug firms. Pharand is also VP health sciences at Innovatech du Grand Montréal, a venture capital firm and an investor in PanGeo. He represents Innovatech on the boards of eight investee firms active in the health sector. Prior to joining Innovatech, Pharand was with Price Waterhouse and then Sweden’s Pharmacia, a multinational firm specializing in biotechnology and pharmaceuticals....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.